Authors: Willard, RJ Turiansky, GW Genest, GP Davis, BJ Diehl, LF

Citation: Rj. Willard et al., Leukemia cutis in a patient with chronic neutrophilic leukemia, J AM ACAD D, 44(2), 2001, pp. 365-369

Authors: LeBrun, CJ Diehl, LF Abbott, KC Welch, PG Yuan, CM

Citation: Cj. Lebrun et al., Life expectancy benefits of cancer screening in the end-stage renal disease population, AM J KIDNEY, 35(2), 2000, pp. 237-243

Authors: Flinn, IW Byrd, JC Morrison, C Jamison, J Diehl, LF Murphy, T Piantadosi, S Seifter, E Ambinder, RF Vogelsang, G Grever, MR

Citation: Iw. Flinn et al., Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies, BLOOD, 96(1), 2000, pp. 71-75

Authors: Shorr, AF Trotta, RF Alkins, SA Hanzel, GS Diehl, LF

Citation: Af. Shorr et al., D-dimer assay predicts mortality in critically ill patients without disseminated intravascular coagulation or venous thromboembolic disease, INTEN CAR M, 25(2), 1999, pp. 207-210

Authors: Diehl, LF Karnell, LH Menck, HR

Citation: Lf. Diehl et al., The national cancer data base report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia, CANCER, 86(12), 1999, pp. 2684-2692

Authors: Byrd, JC McGrail, LH Hospenthal, DR Howard, RS Dow, NA Diehl, LF

Citation: Jc. Byrd et al., Herpes virus infections occur frequently following treatment with fludarabine: results of a prospective natural history study, BR J HAEM, 105(2), 1999, pp. 445-447